A randomized, open-label clinical trial comparing the long-term effects of miltefosine and meglumine antimoniate for mucosal leishmaniasis

Overview of attention for article published in Revista da Sociedade Brasileira de Medicina Tropical, January 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

policy: 1 policy source

Readers on

mendeley: 51 Mendeley

Summary Policy documents

So far, Altmetric has seen 1 policy document that references this research output.

Leishmaniose nas Américas: Diretrizes para o tratamento — Ministério da Saúde

Cited by Ministério da Saúde on 18 Nov 2022

The Ministry of Health is the body of the Federal Executive Branch responsible for organizing and preparing plans and public policies aimed at promoting, preventing and assisting the health of Brazilians.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.